Published: October 3rd 2024 | Updated: October 25th 2024
Aldeyra Therapeutics resubmits NDA for reproxalap for DED signs and symptoms treatment
Published: February 8th 2024 | Updated: October 25th 2024
EnVision Summit 2024: Family time and eye care take center stage
Published: January 24th 2024 | Updated: October 25th 2024
EnVision Summit 2024: Incorporating diversity, family into eye care meetings with Dr Bonnie An Henderson
Published: January 17th 2024 | Updated: October 25th 2024
EnVision Summit 2024: Inside the new Optometry Program and glaucoma panel with Dr Danica Marrelli
Published: February 16th 2024 | Updated: October 25th 2024
EnVision Summit 2024: How women in eye care can navigate a personal IPO journey
Published: February 12th 2024 | Updated: October 25th 2024
EnVision Summit offers innovation in family-friendly format